Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings

References

• Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6(6):212–233. doi:10.1177/2042098615613984
   PubMedGoogle Scholar
• Mangin D, Bahat G, Golomb BA, et al. International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging. 2018;35(7):575–587. doi:10.1007/s40266-018-0554-2
   PubMed Web of Science ®Google Scholar
• Whitman AM. Pharmacology of aging and cancer. Geriatr Oncol. 2020. doi:10.1007/978-3-319-57415-8_65
   Google Scholar
• Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807. doi:10.1007/s40266-013-0106-8
   PubMed Web of Science ®Google Scholar
• Whitman A, DeGregory K, Morris A, Mohile S, Ramsdale E. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study. Support Care Cancer. 2018;26(12):4105–4113. doi:10.1007/s00520-018-4281-3
   PubMed Web of Science ®Google Scholar
• Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33(13):1453–1459. doi:10.1200/JCO.2014.58.7550
   PubMed Web of Science ®Google Scholar
• Todd A, Jansen J, Colvin J, McLachlan A. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. BMC Geriatr. 2018;18:295. doi:10.1186/s12877-018-0978-x
   PubMed Web of Science ®Google Scholar
• Whitman AM, DeGregory KA, Morris AL, Ramsdale EE. A comprehensive look at polypharmacy and medication screening tools for the older cancer patient. Oncologist. 2016;21(6):723–730. doi:10.1634/theoncologist.2015-0492
   PubMed Web of Science ®Google Scholar
• Ostini R, Hegney D, Jackson C, Tett SE. Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm. 2012;18(1):68–72. doi:10.18553/jmcp.2012.18.1.68
   Web of Science ®Google Scholar
• Kouladjian O’Donnell L, Dearing ME. Should hospital admission be used as an opportunity for deprescribing in older adults? Can J Hosp Pharm. 2020;73(4). doi:10.4212/cjhp.v73i4.3029
   Web of Science ®Google Scholar
• Daliri S, Bekker CL, Buurman BM, Scholte op Reimer WJM, van den Bemt BJF, Karapinar-çarkit F. Barriers and facilitators with medication use during the transition from hospital to home: a qualitative study among patients. BMC Health Serv Res. 2019;19(1):204. doi:10.1186/s12913-019-4028-y
   PubMed Web of Science ®Google Scholar
• Scott S, Clark A, Farrow C, et al. Attitudinal predictors of older peoples’ and caregivers’ desire to deprescribe in hospital. BMC Geriatr. 2019;19(1):108. doi:10.1186/s12877-019-1127-x
   PubMed Web of Science ®Google Scholar
• Komagamine J, Sugawara K, Hagane K. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study. BMC Geriatr. 2018;18(1):96. doi:10.1186/s12877-018-0788-1
   Web of Science ®Google Scholar
• Scott S, Clark A, Farrow C, et al. Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity. Int J Clin Pharm. 2018;40(5):991–996. doi:10.1007/s11096-018-0673-1
   PubMed Web of Science ®Google Scholar
• Baysari M, Duong M, Zheng W, et al. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia. BMJ Open. 2019;9(9):e030950. doi:10.1136/bmjopen-2019-030950
   Web of Science ®Google Scholar
• Ailabouni N, Nishtala P, Mangin D, Tordoff J, Cox D. Challenges and enablers of deprescribing: a general practitioner perspective. PLoS One. 2016;11(4):e0151066. doi:10.1371/journal.pone.0151066
   PubMed Web of Science ®Google Scholar
• Flood KL, Carroll MB, Le CV, Brown CJ. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother. 2009;7(3):151–158. doi:10.1016/j.amjopharm.2009.05.002
   PubMedGoogle Scholar
• Mort MK, DeGregory KA, Reufer K, Volodin L, Whitman AM Evaluation of a pharmacist-led deprescribing intervention in stem cell transplant patients [abstract]. Hematology Oncology Pharmacy Association Annual Meeting; April 3; 2019; Fort Worth, TX.
   Google Scholar
• Mort MK, Whitman AM, DeGregory KA, et al. Evaluation of the incidence of in-hospital falls and associated risk factors for adult patients with a hematologic malignancy [abstract]. Vizient University Health System Consortium Pharmacy Network Meeting; December 2; 2017; Orlando, FL.
   Google Scholar
• Flood KL, Carroll MB, Le CV, et al. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol. 2006;24(15):2298–2303. doi:10.1200/JCO.2005.02.8514
   PubMed Web of Science ®Google Scholar
• Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A. Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer. 2007;109(11):2365–2373. doi:10.1002/cncr.22665
   PubMed Web of Science ®Google Scholar
• Marvin V, Jubraj B. Polypharmacy and older people in the hospital environment. Public Policy Aging Rep. 2018;28(4):150–155. doi:10.1093/ppar/pry029
   Google Scholar
• Edey R, Edwards N, Von Sychowski J, Bains A, Spence J, Martinusen D. Impact of deprescribing rounds on discharge prescriptions: an interventional trial. Int J Clin Pharm. 2019;41(1):159–166. doi:10.1007/s11096-018-0753-2
   Web of Science ®Google Scholar
• Potter EL, Lew TE, Sooriyakumaran M, Edwards AM, Tong E, Aung AK. Evaluation of pharmacist-led physician-supported inpatient deprescribing model in older patients admitted to an acute general medical unit. Australas J Ageing. 2019;38(3):206–210. doi:10.1111/ajag.12643
   Web of Science ®Google Scholar
• Thillainadesan J, Gnjidic D, Green S, Hilmer SN. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging. 2018;35(4):303–319. doi:10.1007/s40266-018-0536-4
   PubMed Web of Science ®Google Scholar
• McKean M, Pillans P, Scott IA. A medication review and deprescribing method for hospitalised older patients receiving multiple medications. Intern Med J. 2016;46(1):35–42. doi:10.1111/imj.12906
   Web of Science ®Google Scholar
• Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A. How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2012;2(6):e001461. doi:10.1136/bmjopen-2012-001461
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO global patient safety challenge: medication without harm. 2017. Available from: www.who.int/patientsafety. Accessed April 1, 2021.
   Google Scholar
• Steinman MA, Landefeld CS. Overcoming inertia to improve medication use and deprescribing: patients, pharmacists, and physicians. JAMA. 2018;320(18):1867–1869. doi:10.1001/jama.2018.16473
   PubMed Web of Science ®Google Scholar
• Ramsdale E, Lemelman T, Loh KP, et al. Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers. J Geriatr Oncol. 2018;9(5):534–539. doi:10.1016/j.jgo.2018.02.007
   Web of Science ®Google Scholar
• Yeoh TT, Si P, Chew L. The impact of medication therapy management in older oncology patients. Support Care Cancer. 2013;21(5):1287–1293. doi:10.1007/s00520-012-1661-y
   Web of Science ®Google Scholar
• Price SD, Holman CD, Sanfilippo FM, Emery JD. Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother. 2014;48(1):6–16. doi:10.1177/1060028013504904
   PubMed Web of Science ®Google Scholar
• Corsonello A, Onder G, Abbatecola AM, Guffanti EE, Gareri P, Lattanzio F. Explicit criteria for potentially inappropriate medications to reduce the risk of adverse drug reactions in elderly people: from beers to STOPP/START criteria. Drug Saf. 2012;35(Suppl 1):21–28. doi:10.1007/BF03319100
   Web of Science ®Google Scholar
• Valgus J, Jarr S, Schwartz R, Rice M, Bernard SA. Pharmacist-led, interdisciplinary model for delivery of supportive care in the ambulatory cancer clinic setting. J Oncol Pract. 2010;6(6):e1–e4. doi:10.1200/JOP.2010.000033
   PubMedGoogle Scholar
• Mancini R. Implementing a standardized pharmacist assessment and evaluating the role of a pharmacist in a multidisciplinary supportive oncology clinic. J Support Oncol. 2012;10(3):99–106. doi:10.1016/j.suponc.2011.09.005
   Google Scholar
• Choukroun C, Leguelinel-Blache G, Roux-Marson C, et al. Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer [published online ahead of print, 2020 Aug 13]. J Geriatr Oncol. 2020:S1879-4068(20)30114-4. doi:10.1016/j.jgo.2020.07.010
   Web of Science ®Google Scholar
• Watkins JL, Landgraf A, Barnett CM, Michaud L. Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting. J Am Pharm Assoc. 2012;52(2):170–174. doi:10.1331/JAPhA.2012.11171
   Google Scholar
• Jeong YM, Lee KE, Lee ES, et al. Preoperative medication use and its association with postoperative length of hospital stay in surgical oncology patients receiving comprehensive geriatric assessment. Geriatr Gerontol Int. 2018;18(1):12–19. doi:10.1111/ggi.13127
   Web of Science ®Google Scholar
• Choi KS, Jeong YM, Lee E, et al. Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment. Aging Clin Exp Res. 2018;30(10):1177–1185. doi:10.1007/s40520-018-0904-2
   Web of Science ®Google Scholar
• Westley T, Syrowatka A, Henault D, et al. Patterns and predictors of emergency department visits among older patients after breast cancer surgery: a population-based cohort study. J Geriatr Oncol. 2018;9(3):204–213. doi:10.1016/j.jgo.2017.10.003
   PubMed Web of Science ®Google Scholar
• Jeon MS, Jeong YM, Yee J, et al. Association of pre-operative medication use with unplanned 30-day hospital readmission after surgery in oncology patients receiving comprehensive geriatric assessment. Am J Surg. 2020;219(6):963–968. doi:10.1016/j.amjsurg.2019.06.020
   Web of Science ®Google Scholar
• Ghignone F, van Leeuwen BL, Montroni I, et al. The assessment and management of older cancer patients: a SIOG surgical task force survey on surgeons’ attitudes. Eur J Surg Oncol. 2016;42(2):297–302. doi:10.1016/j.ejso.2015.12.004
   Web of Science ®Google Scholar
• Leger DY, Moreau S, Signol N, et al. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: observational single-center study of 122 patients. J Geriatr Oncol. 2018;9(1):60–67. doi:10.1016/j.jgo.2017.07.015
   Web of Science ®Google Scholar
• Kalsi T, Babic-Illman G, Ross PJ, et al. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer. 2015;112(9):1435–1444. doi:10.1038/bjc.2015.120
   PubMed Web of Science ®Google Scholar
• Deliens C, Deliens G, Filleul O, et al. Drugs prescribed for patients hospitalized in a geriatric oncology unit: potentially inappropriate medications and impact of a clinical pharmacist. J Geriatr Oncol. 2016;7(6):463–470. doi:10.1016/j.jgo.2016.05.001
   Web of Science ®Google Scholar
• Zullig LL, Kimmick G, Smith V, et al. Using a geriatric oncology assessment to link with services (GOAL). J Geriatr Oncol. 2019;10(1):164–168. doi:10.1016/j.jgo.2018.06.004
   Web of Science ®Google Scholar
• By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246. doi:10.1111/jgs.13702
   PubMed Web of Science ®Google Scholar
• Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–679. doi:10.1093/ageing/afn197
   PubMed Web of Science ®Google Scholar
• Hematology/Oncology Pharmacy Association. Further defining the scope of hematology/oncology pharmacy practice. Available from: http://www.hoparx.org/images/hopa/resource-library/guidelines-standards/HOPA18_Scope-2_Web2.pdf. Accessed April 1, 2021.
   Google Scholar
• Knez L, Laaksonen R, Duggan C. Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiol Oncol. 2010;44(4):249–256. doi:10.2478/v10019-010-0040-x
   Web of Science ®Google Scholar
• Sokol KC, Knudesen JF, Li MM. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther. 2007;32(2):169–175. doi:10.1111/j.1365-2710.2007.00815.x
   PubMed Web of Science ®Google Scholar
• Loui H, Benyamini P, Maldini G. Major oncologic surgery at a community hospital. Hawaii J Med Public Health. 2017;76(2):39.
   Google Scholar
• Hardacre JM, Raigani S, Dumot J. Starting a high-quality pancreatic surgery program at a community hospital. J Gastrointest Surg. 2015;19(12):2178–2182. doi:10.1007/s11605-015-2937-6
   Web of Science ®Google Scholar
• Chung C, Collins A, Cui N. Development and implementation of an interdisciplinary oncology program in a community hospital. Am J Health Syst Pharm. 2011;68(18):1740–1747. doi:10.2146/ajhp100626
   PubMed Web of Science ®Google Scholar
• Lynch MP, Marcone D, Kagan SH. Developing a multidisciplinary geriatric oncology program in a community cancer center. Clin J Oncol Nurs. 2007;11(6):929–933. doi:10.1188/07.CJON.929-933
   Google Scholar
• Ruder AD, Smith DL, Madsen MT, Kass FH 3rd. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract. 2011;17(4):425–432. doi:10.1177/1078155210389216
   PubMedGoogle Scholar
• McPherson AL, McPherson ML. Deprescribing: right-sizing medication regimens to optimize outcomes in palliative care. Curr Geriatr Rep. 2019;8:21–30. doi:10.1007/s13670-019-0274-4
   Web of Science ®Google Scholar
• Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Barras M. Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Support Care Cancer. 2014;22:1113–1119. doi:10.1007/s00520-013-2098-7
   Web of Science ®Google Scholar
• Riechelmann RP, Krzyzanowska MK, Zimmermann C. Futile medication use in terminally ill cancer patients. Support Care Cancer. 2009;17(6):745–748. doi:10.1007/s00520-008-0541-y
   PubMed Web of Science ®Google Scholar
• Fede A, Miranda M, Antonangelo D, et al. Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer. 2011;19(9):1313–1318. doi:10.1007/s00520-010-0947-1
   Web of Science ®Google Scholar
• Todd A, Husband A, Andrew I, Pearson SA, Lindsey L, Holmes H. Inappropriate prescribing of preventative medication in patients with life-limiting illness. BMJ Support Palliat Care. 2017;7(2):113–121. doi:10.1136/bmjspcare-2015-000941
   PubMed Web of Science ®Google Scholar
• Lindsay J, Dooley M, Martin J, et al. The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’. Support Care Cancer. 2015;23(1):71–78. doi:10.1007/s00520-014-2322-0
   PubMed Web of Science ®Google Scholar
• Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430–434.
   PubMed Web of Science ®Google Scholar
• Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Int Med. 2010;170(18):1648–1654. doi:10.1001/archinternmed.2010.355
   PubMed Web of Science ®Google Scholar
• Bilek AJ, Yuval L, Kab H, Andreev P, Garfinkel D. Teaching physicians the GPGP method promotes deprescribing in both inpatient and outpatient settings. Ther Adv Drug Saf. 2019;10:2042098619895914. doi:10.1177/2042098619895914
   Web of Science ®Google Scholar
• Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166(6):605–609. doi:10.1001/archinte.166.6.605
   PubMedGoogle Scholar
• Gardner E. Deprescribing in end-of-life care. Br J Community Nurs. 2019;24(10):474–477. doi:10.12968/bjcn.2019.24.10.474
   PubMedGoogle Scholar
• Riker GI, Setter SM. Polypharmacy in older adults at home: what it is and what to do about it–implications for home healthcare and hospice. Home Healthc Nurse. 2012;30(8):474–487. doi:10.1097/NHH.0b013e31826502dd
   PubMedGoogle Scholar
• DeAngelis J, Lowry MF. Hospital readmissions in hospice patients: evaluation of medication-related causes for readmission. Am J Hosp Palliat Care. 2020;1049909120959641. doi:10.1177/1049909120959641
   Web of Science ®Google Scholar
• Wilson MG, Lee TC, Hass A, Tannenbaum C, McDonald EG. EMPOWERing hospitalized older adults to deprescribe sedative hypnotics: a pilot study. J Am Geriatr Soc. 2018;66(6):1186–1189. doi:10.1111/jgs.15300
   Web of Science ®Google Scholar
• Cao T, Johnson A, Coogle J, et al. Incidence and characteristics associated with hospital readmission after discharge to home hospice. J Palliat Med. 2020;23(2):233–239. doi:10.1089/jpm.2019.0246
   Web of Science ®Google Scholar
• Garfinkel D, Ilin N, Waller A, Torkan-Zilberstein A, Zilberstein N, Gueta I. Inappropriate medication use and polypharmacy in end-stage cancer patients: isn’t it the family doctor’s role to de-prescribe much earlier? Int J Clin Pract. 2018;72(4):e13061. doi:10.1111/ijcp.13061
   Web of Science ®Google Scholar
• Huisman BAA, Geijteman ECT, Dees MK, et al. Role of nurses in medication management at the end of life: a qualitative interview study. BMC Palliat Care. 2020;19(1):68. doi:10.1186/s12904-020-00574-5
   Web of Science ®Google Scholar
• Suchanek D. The rise and role of specialty pharmacy. Biotechnol Healthc. 2005;2(5):31–35.
   Google Scholar
• Shreman J, Davis L, Daniels K. Addressing the polypharmacy conundrum. US Pharm. 2017;42(6):14–20.
   Web of Science ®Google Scholar
• Cooper JA, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people: a cochrane systematic review. BMJ Open. 2015;5(12):e009235. doi:10.1136/bmjopen-2015-009235
   PubMed Web of Science ®Google Scholar
• Schwartz RN, Eng KJ, Frieze DA, et al. NCCN task force report: specialty pharmacy. J Natl Compr Canc Netw. 2010;8(Suppl 4):S1–S12. doi:10.6004/jnccn.2010.0127
   Google Scholar
• Costa E, Giardini A, Savin M, et al. Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence. 2015;9:1303–1314. doi:10.2147/PPA.S87551
   PubMed Web of Science ®Google Scholar
• Tschida S, Aslam S, Las L, et al. Outcomes of a specialty pharmacy program for oral oncology medications. Am J Pharm Benefits. 2012;4(4):165–174.
   Google Scholar